Connor, Clark & Lunn Investment Management Ltd.

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1596800 VANCOUVER, A1

Back to ADPT Full portfolio

Position in ADPT

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$9,016,822

-$586,279 QoQ

Shares Held

649,627

+9.9% QoQ

Ownership

0.406%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ADPT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $206,312,128 across 18 Diagnostics & Research names. ADPT ranks #7 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MEDP	Medpace Holdings, Inc.	134,838	$64,747,859
2	ILMN	Illumina, Inc.	202,742	$24,989,978
3	DHR	Danaher Corp /De/	129,426	$24,539,169
4	GH	Guardant Health, Inc.	254,788	$23,534,767
5	CRL	Charles River Laboratories International, Inc.	54,570	$9,413,325
6	CSTL	Castle Biosciences Inc	377,082	$9,257,363
7	ADPT	Adaptive Biotechnologies Corp This page	649,627	$9,016,822
8	NEO	Neogenomics Inc	938,052	$6,960,345

All Filings in ADPT

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,016,822	649,627	+9.9%	Shares	Sole	2026-05-11
2025-12-31	$9,603,101	591,324	+957.0%	Shares	Sole	2026-02-10
2025-09-30	$836,922	55,944	-37.2%	Shares	Sole	2025-11-13
2022-12-31	$680,869	89,119	-66.9%	Shares	Sole	2023-02-10
2022-09-30	$1,915,386	269,015	+100.5%	Shares	Sole	2022-11-10
2022-06-30	$1,085,718	134,205	+532.5%	Shares	Sole	2022-08-05
2022-03-31	$294,505	21,218	+17.8%	Shares	Sole	2022-05-12
2021-12-31	$505,360	18,010	-23.6%	Shares	Sole	2022-02-10
2021-09-30	$801,280	23,574	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.